Superoxide dismutase and the death of motoneurons in ALS

J S Beckman1, A G Estévez, J P Crow

  • 1Linus Pauling Institute, and Dept of Biochemistry and Biophysics, Oregon State University, Corvallis 97331, USA. joe.beckman@orst.edu

Insights

Zinc deficiency in Cu-Zn superoxide dismutase (SOD) causes motoneuron death in ALS. This finding suggests targeting Zn-deficient SOD could be a therapeutic strategy for all forms of amyotrophic lateral sclerosis (ALS).

Area of Science:

  • Neuroscience
  • Biochemistry
  • Genetics

Background:

  • Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by motoneuron loss.
  • Mutations in Cu-Zn superoxide dismutase (SOD) are a known cause of ALS, affecting 2-3% of patients.
  • These mutations compromise SOD's structural integrity and reduce its zinc (Zn) binding affinity.

Purpose of the Study:

  • To investigate the role of Zn-deficient SOD in motoneuron apoptosis.
  • To explore whether Zn deficiency in wild-type SOD contributes to ALS pathogenesis.
  • To identify Zn-deficient SOD as a potential therapeutic target for all ALS cases.

Main Methods:

  • Analysis of SOD structure and Zn binding affinity in ALS-associated mutations.
  • Induction of Zn deficiency in both mutant and wild-type SOD.
  • Assessment of motoneuron apoptosis in response to Zn-deficient SOD.

Main Results:

  • Zn-deficient SOD, regardless of mutation status, induces motoneuron apoptosis.
  • The mechanism involves peroxynitrite formation.
  • Zn-deficient wild-type SOD exhibits toxicity comparable to Zn-deficient mutant SOD.

Conclusions:

  • Loss of Zn from SOD is a critical factor in motoneuron degeneration in ALS.
  • Zn-deficient SOD is implicated in both familial and sporadic ALS cases.
  • Targeting Zn-deficient SOD presents a promising therapeutic avenue for all forms of ALS.

Related Concept Videos

Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...